Muttalip Özbek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muttalip Özbek has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Eşref Akıl
Department of Neurology, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye
6 shared publications - Hamza Gültekin
Dicle University
4 shared publications - Fidel Demir
Department of Neurology, Selahaddin Eyyubi State Hospital, Diyarbakır, Turkey
2 shared publications - Adalet Arıkanoğlu
Department of Neurology, Faculty of Medicine, Dicle University, Diyarbakir 21090, Turkey
1 shared publication Ayşe Kaya
Dicle University
1 shared publication- Cumali Çetiner
Department of Neurology, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye
1 shared publication
Latest Publications
- 20 August 2026
- Published by Taylor & Francis in Neurological Research
- p. 1-12
Early cerebral hemodynamic patterns after endovascular thrombectomy: a prospective TCCD analysis of aspiration and combined techniques
1. Acute ischemic stroke remains one of the leading causes of mortality and long-term disability worldwide, and prognosis is largely dependent on achieving timely and effective reperfusion, particu...
- 20 August 2026
- Published by Taylor & Francis in Neurological Research
- p. 1-12
Early cerebral hemodynamic patterns after endovascular thrombectomy: a prospective TCCD analysis of aspiration and combined techniques
1. Acute ischemic stroke remains one of the leading causes of mortality and long-term disability worldwide, and prognosis is largely dependent on achieving timely and effective reperfusion, particu...
- Open Access
- 30 April 2026
- Published by Turkish Society of Cerebrovascular Diseases in Turkish Journal of Cerebrovascular Diseases
- Vol. 32 (1) , 30-41
The role of prognostic nutritional index in quality of life and mortality after aneurysmal subarachnoid hemorrhage: A single-center retrospective study
Background: Aneurysmal subarachnoid hemorrhage (aSAH), a life-threatening neurological emergency, is characterized by blood accumulation in the subarachnoid space due to the rupture of an aneurysm. In this study, we investigated the effect of the Prognostic Nutritional Index on the prognosis and quality of life in patients with aneurysmal subarachnoid hemorrhage. Methods: A total of 126 aSAH patients who underwent endovascular treatment at the Stroke Center of Dicle University, Department of Neurology between January 1, 2020, and January 1, 2024, were included. After excluding 2 patients with chronic kidney failure, 1 with malignancy, 1 with a procedure-related complication, and 8 due to early mortality, 114 patients were included in the study. Results: As a result of our study, a relationship was found between preoperative and postoperative 72-hour PNI values and functional status. Additionally, a relationship was identified between postoperative 72-hour PNI values and mortality as well as infection. In our study, multivariable logistic regression analysis was used to evaluate the relationship between postoperative 72-hour PNI values and mortality. Postoperative 72-hour PNI was found to have a statistically significant relationship with the SF-36 energy subscale (p = 0.007). Discussion and Conclusion: Albumin and lymphocyte values used to calculate PNI can be utilized to predict prognosis in patients with aSAH. The simplicity, low cost, and non-invasive nature of PNI calculation make it a clinically valuable tool.
- 30 April 2026
- Published by Turkish Society of Cerebrovascular Diseases in Turkish Journal of Cerebrovascular Diseases
- Vol. 32 (1) , 30-41
Open AccessThe role of prognostic nutritional index in quality of life and mortality after aneurysmal subarachnoid hemorrhage: A single-center retrospective study
Background: Aneurysmal subarachnoid hemorrhage (aSAH), a life-threatening neurological emergency, is characterized by blood accumulation in the subarachnoid space due to the rupture of an aneurysm. In this study, we investigated the effect of the Prognostic Nutritional Index on the prognosis and quality of life in patients with aneurysmal subarachnoid hemorrhage. Methods: A total of 126 aSAH patients who underwent endovascular treatment at the Stroke Center of Dicle University, Department of Neurology between January 1, 2020, and January 1, 2024, were included. After excluding 2 patients with chronic kidney failure, 1 with malignancy, 1 with a procedure-related complication, and 8 due to early mortality, 114 patients were included in the study. Results: As a result of our study, a relationship was found between preoperative and postoperative 72-hour PNI values and functional status. Additionally, a relationship was identified between postoperative 72-hour PNI values and mortality as well as infection. In our study, multivariable logistic regression analysis was used to evaluate the relationship between postoperative 72-hour PNI values and mortality. Postoperative 72-hour PNI was found to have a statistically significant relationship with the SF-36 energy subscale (p = 0.007). Discussion and Conclusion: Albumin and lymphocyte values used to calculate PNI can be utilized to predict prognosis in patients with aSAH. The simplicity, low cost, and non-invasive nature of PNI calculation make it a clinically valuable tool.
- 20 October 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 259, 109200
Multi-inflammatory index as a predictor of futile recanalization in acute ischemic stroke patients undergoing mechanical thrombectomy
- 20 October 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 259, 109200
Multi-inflammatory index as a predictor of futile recanalization in acute ischemic stroke patients undergoing mechanical thrombectomy
- Open Access
- 24 August 2025
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- p. 1-8
Dynamic changes in serum glutamine levels and clinical outcomes in acute ischemic stroke: a prospective analysis
Background: This is the first study to focus exclusively on a pure ischemic stroke cohort, exploring serum glutamine levels and their association with oxidative stress markers and clinical outcomes. Methods: 50 patients diagnosed with ischemic stroke were included in our study. We used methods such as LC-MS/MS to measure glutamine levels with high accuracy. Oxidative stress markers, including total antioxidant capacity (TAC) and total oxidant status (TOS), were also analyzed. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS), and functional outcomes were evaluated using the modified Rankin Scale (mRS) at 90 days. Results: Serum glutamine levels varied significantly based on stroke severity. Patients with NIHSS ≥16 demonstrated significantly lower glutamine levels compared to those with NIHSS 16.
- 24 August 2025
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- p. 1-8
Open AccessDynamic changes in serum glutamine levels and clinical outcomes in acute ischemic stroke: a prospective analysis
Background: This is the first study to focus exclusively on a pure ischemic stroke cohort, exploring serum glutamine levels and their association with oxidative stress markers and clinical outcomes. Methods: 50 patients diagnosed with ischemic stroke were included in our study. We used methods such as LC-MS/MS to measure glutamine levels with high accuracy. Oxidative stress markers, including total antioxidant capacity (TAC) and total oxidant status (TOS), were also analyzed. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS), and functional outcomes were evaluated using the modified Rankin Scale (mRS) at 90 days. Results: Serum glutamine levels varied significantly based on stroke severity. Patients with NIHSS ≥16 demonstrated significantly lower glutamine levels compared to those with NIHSS 16.
- Open Access
Depression, Anxiety, and MSQOL-54 Outcomes in RRMS Patients Receiving Fingolimod or Cladribine: A Cross-Sectional Comparative Study
Background and Objectives: Multiple sclerosis (MS) is a chronic immune-mediated neurological disorder that primarily affects young adults and is frequently accompanied by psychiatric comorbidities such as depression and anxiety, both of which significantly diminish patients’ quality of life (QoL). This study investigated the effect of two oral disease-modifying therapies (DMTs), fingolimod and cladribine, on mental health and QoL in patients with relapsing-remitting MS (RRMS). The aim of the study was to compare levels of depression, anxiety, and health-related quality of life (HRQoL) in RRMS patients treated with fingolimod or cladribine, and to evaluate their associations with clinical and radiological parameters. Materials and Methods: Eighty RRMS patients aged 18 to 50 years with Expanded Disability Status Scale (EDSS) scores of 3.0 or less, no recent disease relapse, and no history of antidepressant use were enrolled. Forty patients were treated with fingolimod and forty with cladribine. Depression and anxiety were assessed using the Hamilton Depression Rating Scale (HDRS) and the Hamilton Anxiety Rating Scale (HARS). QoL was evaluated using the Multiple Sclerosis QoL-54 (MSQOL-54) instrument. Additional clinical data, including MRI-based lesion burden, EDSS scores, age, disease duration, and occupational status, were collected. Results: No statistically significant differences were observed between the two groups regarding HDRS and HARS scores (p > 0.05). However, patients treated with fingolimod had significantly higher scores in the Energy/Fatigue subdomain (7.55 ± 2.02 vs. 6.56 ± 2.57, p = 0.046) and Composite Mental Health (CMH) score (64.73 ± 15.01 vs. 56.00 ± 18.93, p = 0.029) compared to those treated with cladribine. No significant differences were found in the independent items of the MSQOL-54. A negative correlation was identified between total lesion load and QoL scores. Conclusions: Although fingolimod and cladribine exert comparable effects on depression and anxiety levels, fingolimod may be associated with better mental health outcomes and reduced fatigue in RRMS patients. Furthermore, lesion burden and clinical parameters such as age and EDSS score may independently influence QoL, regardless of the DMT used.
Open AccessDepression, Anxiety, and MSQOL-54 Outcomes in RRMS Patients Receiving Fingolimod or Cladribine: A Cross-Sectional Comparative Study
Background and Objectives: Multiple sclerosis (MS) is a chronic immune-mediated neurological disorder that primarily affects young adults and is frequently accompanied by psychiatric comorbidities such as depression and anxiety, both of which significantly diminish patients’ quality of life (QoL). This study investigated the effect of two oral disease-modifying therapies (DMTs), fingolimod and cladribine, on mental health and QoL in patients with relapsing-remitting MS (RRMS). The aim of the study was to compare levels of depression, anxiety, and health-related quality of life (HRQoL) in RRMS patients treated with fingolimod or cladribine, and to evaluate their associations with clinical and radiological parameters. Materials and Methods: Eighty RRMS patients aged 18 to 50 years with Expanded Disability Status Scale (EDSS) scores of 3.0 or less, no recent disease relapse, and no history of antidepressant use were enrolled. Forty patients were treated with fingolimod and forty with cladribine. Depression and anxiety were assessed using the Hamilton Depression Rating Scale (HDRS) and the Hamilton Anxiety Rating Scale (HARS). QoL was evaluated using the Multiple Sclerosis QoL-54 (MSQOL-54) instrument. Additional clinical data, including MRI-based lesion burden, EDSS scores, age, disease duration, and occupational status, were collected. Results: No statistically significant differences were observed between the two groups regarding HDRS and HARS scores (p > 0.05). However, patients treated with fingolimod had significantly higher scores in the Energy/Fatigue subdomain (7.55 ± 2.02 vs. 6.56 ± 2.57, p = 0.046) and Composite Mental Health (CMH) score (64.73 ± 15.01 vs. 56.00 ± 18.93, p = 0.029) compared to those treated with cladribine. No significant differences were found in the independent items of the MSQOL-54. A negative correlation was identified between total lesion load and QoL scores. Conclusions: Although fingolimod and cladribine exert comparable effects on depression and anxiety levels, fingolimod may be associated with better mental health outcomes and reduced fatigue in RRMS patients. Furthermore, lesion burden and clinical parameters such as age and EDSS score may independently influence QoL, regardless of the DMT used.
- Open Access
- 1 March 2025
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 31 (1) , 16-24
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Objectives: This study aimed to investigate the relationships between serum S100 calcium binding protein, neuron-specific enolase, matrix metalloproteinase-9, interleukin-6, N-terminal probrain natriuretic peptide, and N-methyl-D-aspartate receptor subunit NR2 biomarkers and futile recanalization in patients with acute ischemic stroke who were successfully recanalized with endovascular treatment. Patients and methods: In this study, 44 patients (25 males, 19 females; mean age: 62.2±14.1 years; range, 26 to 81 years) with acute ischemic stroke due to acute anterior circulation large-vessel occlusion were prospectively analyzed between May 15, 2020 and October 15, 2020. Blood samples were taken at admission, as well as 6 and 24 h after endovascular treatment. A modified Rankin Scale (mRS) was used on the 90 th day to identify futile reperfusion. Patients with mRS scores ≤2 were included in the favorable reperfusion group (n=20), while patients with mRS scores ≥3 were considered to exhibit futile reperfusion (n=24). Results: There were no significant differences between the biomarker levels of the groups (p>0.05). There was no statistically significant correlation between biomarkers and 90-day mRS scores (p>0.05). Higher National Institute of Health Stroke Scale (NIHSS) scores (p=0.004), higher number of retriever passes (p=0.032), and higher diastolic blood pressure (p=0.037) were associated with futile recanalization. Multivariate logistic regression analysis showed that a higher NIHSS score at admission was an independent predictor of futile recanalization (odds ratio=1.216, 95% confidence interval 1.01-1.46, p=0.038). Conclusion: A higher NIHSS score at admission was an independent predictor for futile recanalization. However, we concluded that biomarker levels were not associated with futile recanalization.
- 1 March 2025
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 31 (1) , 16-24
Open AccessThe potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Objectives: This study aimed to investigate the relationships between serum S100 calcium binding protein, neuron-specific enolase, matrix metalloproteinase-9, interleukin-6, N-terminal probrain natriuretic peptide, and N-methyl-D-aspartate receptor subunit NR2 biomarkers and futile recanalization in patients with acute ischemic stroke who were successfully recanalized with endovascular treatment. Patients and methods: In this study, 44 patients (25 males, 19 females; mean age: 62.2±14.1 years; range, 26 to 81 years) with acute ischemic stroke due to acute anterior circulation large-vessel occlusion were prospectively analyzed between May 15, 2020 and October 15, 2020. Blood samples were taken at admission, as well as 6 and 24 h after endovascular treatment. A modified Rankin Scale (mRS) was used on the 90 th day to identify futile reperfusion. Patients with mRS scores ≤2 were included in the favorable reperfusion group (n=20), while patients with mRS scores ≥3 were considered to exhibit futile reperfusion (n=24). Results: There were no significant differences between the biomarker levels of the groups (p>0.05). There was no statistically significant correlation between biomarkers and 90-day mRS scores (p>0.05). Higher National Institute of Health Stroke Scale (NIHSS) scores (p=0.004), higher number of retriever passes (p=0.032), and higher diastolic blood pressure (p=0.037) were associated with futile recanalization. Multivariate logistic regression analysis showed that a higher NIHSS score at admission was an independent predictor of futile recanalization (odds ratio=1.216, 95% confidence interval 1.01-1.46, p=0.038). Conclusion: A higher NIHSS score at admission was an independent predictor for futile recanalization. However, we concluded that biomarker levels were not associated with futile recanalization.